CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2016 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Charles River Laboratories International, Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2016 to Q4 2024.
  • Charles River Laboratories International, Inc. Deferred Income Tax Liabilities, Net for the quarter ending December 28, 2024 was $107M, a 44.1% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $107M -$84.4M -44.1% Dec 28, 2024 10-K 2025-02-19
Q3 2024 $168M -$17.6M -9.48% Sep 28, 2024 10-Q 2024-11-06
Q2 2024 $165M -$42.2M -20.4% Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $180M -$32.2M -15.2% Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $191M -$24.2M -11.2% Dec 30, 2023 10-K 2025-02-19
Q3 2023 $185M -$10.7M -5.46% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $207M -$22.6M -9.84% Jul 1, 2023 10-Q 2023-08-09
Q1 2023 $212M -$18.7M -8.08% Apr 1, 2023 10-Q 2023-05-11
Q4 2022 $216M -$24.1M -10.1% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $196M -$63.1M -24.4% Sep 24, 2022 10-Q 2022-11-02
Q2 2022 $230M -$32.5M -12.4% Jun 25, 2022 10-Q 2022-08-03
Q1 2022 $231M +$23.9M +11.6% Mar 26, 2022 10-Q 2022-05-04
Q4 2021 $240M +$22.7M +10.5% Dec 25, 2021 10-K 2023-02-22
Q3 2021 $259M +$56.7M +28% Sep 25, 2021 10-Q 2021-11-03
Q2 2021 $263M +$60.8M +30.1% Jun 26, 2021 10-Q 2021-08-04
Q1 2021 $207M +$9.92M +5.03% Mar 27, 2021 10-Q 2021-05-04
Q4 2020 $217M +$49.7M +29.7% Dec 26, 2020 10-K 2022-02-16
Q3 2020 $202M +$36.9M +22.3% Sep 26, 2020 10-Q 2020-10-29
Q2 2020 $202M +$20M +11% Jun 27, 2020 10-Q 2020-08-05
Q1 2020 $197M +$45.2M +29.8% Mar 28, 2020 10-Q 2020-05-07
Q4 2019 $167M +$23.6M +16.5% Dec 28, 2019 10-K 2021-02-17
Q3 2019 $165M +$20.1M +13.9% Sep 28, 2019 10-Q 2019-11-06
Q2 2019 $182M +$29M +19% Jun 29, 2019 10-Q 2019-07-31
Q1 2019 $152M Mar 30, 2019 10-Q 2019-05-07
Q4 2018 $144M +$54.1M +60.4% Dec 29, 2018 10-K 2020-02-11
Q3 2018 $145M Sep 29, 2018 10-Q 2018-11-07
Q2 2018 $153M Jun 30, 2018 10-Q 2018-08-08
Q4 2017 $89.5M +$33.8M +60.7% Dec 30, 2017 10-K 2019-02-13
Q4 2016 $55.7M Dec 31, 2016 10-K 2018-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.